# Plain Language Summary: Sickle Cell Disease Treatment Centers Act of 2022

This bill creates a new federal program to establish specialized treatment centers specifically for people with sickle cell disease across the United States. Sickle cell disease is a serious inherited blood disorder that causes severe pain, organ damage, and other life-threatening complications. Currently, many patients struggle to find doctors and hospitals that understand how to properly treat this condition, so this bill aims to fix that by funding dedicated centers of excellence where patients can receive expert care all in one place.

The bill directs the federal government to set up these specialized centers at hospitals and medical facilities around the country. These centers would bring together teams of doctors, nurses, and specialists who focus specifically on sickle cell disease treatment and research. Patients would have access to pain management, blood transfusions, organ transplants, genetic counseling, and other advanced treatments—all coordinated by experts who understand the unique challenges of this disease. The centers would also conduct research to develop better treatments and cures.

The funding would help cover the costs of running these centers, training medical staff, and providing care to patients regardless of their ability to pay. This is particularly important because sickle cell disease disproportionately affects Black Americans and other communities of color, and many patients in these communities have historically had difficulty accessing quality healthcare. By creating these specialized centers, the bill aims to ensure that everyone with sickle cell disease, no matter where they live, has access to the best possible medical care and the latest treatment options.

Sickle Cell Disease Treatment Centers Act of 2022

Van Hollen, Chris

Sickle Cell Disease Treatment Centers Act of 2022 This bill directs the Department of Health and Human Services to award grants for establishing sickle cell disease treatment centers that operate using a hub-and-spoke framework to provide integrated, longitudinal health care for patients with the disease and individuals with sickle cell trait. Grant recipients must be networks comprised of (1) a hospital, clinic, or university health center; (2) at least one federally qualified health center or other health care organization that incorporates community health workers into the care team; and (3) at least one community-based organization. Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.